Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population is a research paper published in Drug Metabolism and Disposition (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: T32 GM086330
NIAID NIH HHS
Grant: HHSN272201300017I
NICHD NIH HHS
Grant: HHSN275201000003I
NIAID NIH HHS
Grant: UM1 AI068634
NIAID NIH HHS
Grant: UM1 AI068636
NICHD NIH HHS
Grant: R01 HD102949
NIAID NIH HHS
Grant: K24 AI143971
NICHD NIH HHS
Grant: R01 HD096435
NICHD NIH HHS
Grant: R01 HD076676
FDA HHS
Grant: U18 FD006298
NICHD NIH HHS
Grant: K23 HD083465
National Institutes of Health
Grant: 5R01HD096435-03
Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity
National Institutes of Health
Grant: 5T32GM086330-08
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
National Institutes of Health
Grant: 5U18FD006298-03
Global Pediatric Clinical Trials Network
National Institutes of Health
Grant: 1R01HD102949-01A1
Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants
National Institutes of Health
Grant: 5K23HD083465-05
Use of Physiologically-Based PK/PD Models to Streamline Drug Approvals
National Institutes of Health
Grant: 5K24AI143971-05
Mentoring in Clinical Pharmacology and Early Phase Trials
FWCI
2.33
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals